CARE Congress 2018 NEW EARLYBIRD.png


Friday, April 6th, 2018
Registration & Lunch 11:15 - 12:00 pm
Meeting Sessions 12:00 - 5:00 pm


Shangri-La Hotel,
188 University Ave, Toronto, ON
Queens Park South Meeting Room


John Marshall, MD - McMaster University
John Kuruvilla, MD - Princess Margaret Cancer Centre

Join the CARE™ Faculty in Toronto for the Second Annual National CARE™ Congress!

The second National CARE™ Congress: Update on Biosimilars and Access to Innovation will be held at the Shangri-La Hotel in Toronto on April 6th, 2018. This year’s meeting seeks to address questions and considerations regarding biosimilars in Canada and how they build towards a larger discussion on access to innovative medicine. This meeting will include discussion and will provide a platform for medical specialists and key stakeholders across multiple fields to meet, collaborate, and discuss concepts that have a practical impact on the Canadian healthcare landscape.  

The Aim

The CARE™ Congress aims to allow assembled CARE™ faculty and panelists to consider the use of biosimilars and align on the importance of access to innovation. 

The CARE™ Faculty is pleased to welcome a robust speaker line-up, with representation from Canadian researchers, clinicians, government,  public and private funding agencies, health economists, hospital pharmacists, nurses, advocacy groups, ethicists and legal experts.

Register before February 16th for 20% off!

Meeting Format

This year's congress will split into two sections addressing different topics in the Canadian healthcare landscape.

Session 1 - Update on biosimilars
The meeting will open with an update on where CARE™ Faculty and assembled stakeholders sit on a continuum of understanding, as well as information and data needed to increase comfort levels and adoption of biosimilars.

Session 2 - Access to innovation
The second part of the meeting will focus on access to innovation.
A series of speakers will:

  • Review impact of innovative medicine
  • Project where innovation is heading and the costs associated
  • Review approval process for innovation at federal level and access considerations by both public and private payers
  • Reflect on systemic challenges to access innovative medicine
  • Consider the ethical, legal and economic challenges with access to innovation

Representatives will speak on their area of expertise to assembled CARE Faculty and audience members, sharing insights and perspectives.

Meeting Agenda

Session 1: Update on Biosimilars

12:00 - 12:15 PM Introduction

12:15 - 12:30 PM CARE Biosimilars Update

12:30 - 12:45 PM CARE Primer on Biosimilars 

12:45 - 1:15 PM Faculty/Panelist Discussion

1:15 - 1:20 PM Session 1 Summary and Next Steps

Session 2: Access to Innovation

1:20 - 1:30 PM Introduction

1:30 - 1:45 PM The State of Healthcare in Canada

1:45 - 2:00 PM Faculty/Panelist Discussion

2:00 - 2:20 PM Translational Science 

2:20 - 2:30 PM Faculty/Panelist Discussion

2:30 - 2:50 PM BREAK

2:50 - 3:05 PM Drug Approval and Public Pricing 

3:05 - 3:20 PM Faculty/Panelist Discussion

3:20 - 3:50 PM Public and Private Payer Perspectives 

3:50 - 4:05 PM Faculty/Panelist Discussion

4:05 - 4:20 PM Canadian Healthcare Ecosystem

4:20 - 4:35 PM Patient Advocacy

4:40 - 4:55 PM Session 2 Summary and Next Steps 

4:55 - 5:00 PM Concluding Remarks 

5:00 PM Congress Reception

Speaker details to come closer to event date.

Additional Meeting Details

Parking at the Shangri-La Hotel Toronto Valet parking is offered 24hrs/day

0.1 km away from event 150 York Street - Adelaide Place - Lot #322
0.13 km away from event 211 Adelaide Street West - Lot #472
0.17 km away from event 130 Adelaide Street - Lot #324 - Richmond Adelaide C
0.25 km away from event 333 Bay Street - Bay Adelaide Centre - Lot #149

Additional Resources:
Green P on-street Parking
Toronto Impark Parking Garage Search